Flow Cytometry - Shaping the Future of Drug Development—What It Means for Aging Americans

Why a cancer researcher with a high genetic risk wants AI development to slow down

A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona

Why a cancer researcher with a high genetic risk wants AI development to slow down

A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona

Cell- and Virus-Bank Characterization in Product Development: A Risk-Based, Phase-Appropriate Framework for Quality Control

Cellular reprogramming emerges as a promising but unproven approach to reversing aging

The article explores "reprogramming" as a buzzy new approach to reversing aging, focusing on cellular reprogramming techniques that aim to r

Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss

Life Biosciences has dosed the first human patient with ER-100, a cellular rejuvenation therapy designed to reverse age-related sight loss b

Understanding Autophagy: The Body's Cellular Cleanup System for Healthy Aging

Autophagy, the body's natural cellular cleanup and repair process, has emerged as a key focus in longevity research. Once a niche biological

Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing